ABSTRACT

Presented by Rick Doblin, Ph.D., Executive Director MAPS.

We're now in the midst of a worldwide renaissance in psychedelic research, after decades of political suppression. Scientists from around the world will present their new findings at the largest psychedelic conference to take place in the US in 17 years, on April 15-18, 2010, in San Jose, CA (http://www.maps.org/conference/ ). Even media reports, which usually mention in passing the widespread use of psychedelics by the counterculture in the 1960s, are more hopeful than alarming. In this talk, we'll review the factors which led to the backlash and the lessons to be learned, discuss how the FDA opened the door to research around the world, how the ghost of Timothy Leary was buried at Harvard, and how Burning Man struggles to respond to people who have difficult psychedelic experiences. We'll conclude by explaining how non-profit drug development, initially of MDMA-assisted psychotherapy for postraumatic stress disorder (PTSD), can transform psychedelics into FDA-approved prescription medicines and can lay the groundwork for the successful, long-term integration of psychedelics into the mainstream of medicine, religion, art, creativity, and celebration.

Rick studied with Stan Grof, M.D., and was in the first group to become certified as holotropic breathwork practitioners. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise "healthy" people, and to also become a legally licensed psychedelic therapist. He resides in Boston with his wife and three children.